The TCGA-LIHC and qRT-PCR results both indicate that EGFR and PTGS2 expression is significantly downregulated in HCC, providing preliminary support for the reliability of the molecular docking results in this study. The gene discussed is EGFR; the disease is hepatocellular carcinoma.